Lei Wanli, Rushton John J, Davis Lisa M, Liu Fan, Ness Scott A
Department of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131-0001, USA.
J Biol Chem. 2004 Jul 9;279(28):29519-27. doi: 10.1074/jbc.M403133200. Epub 2004 Apr 21.
The A-Myb and c-Myb transcription factors share a highly conserved DNA-binding domain and activate the same promoters in reporter gene assays. However, the two proteins have distinct biological activities, and expressing them individually in human cells leads to the activation of distinct sets of endogenous genes, suggesting that each protein has a unique transcriptional specificity. Here, the structural and functional features of the Myb proteins were compared, using assays of endogenous gene expression to measure changes in specificity. When the Myb proteins were tested in different cell types, they activated unique and nearly nonoverlapping sets of genes in each cellular context. Deletion and domain swap experiments identified small, discreet positive and negative elements in A-Myb and c-Myb that were required for the regulation of specific genes, such as DHRS2, DSIPI, and mim-1. The results suggest that individual functional elements in the transcriptional activation domains are responsible for activating specific cellular genes in a context-specific manner. The results also have important implications for interpreting results from reporter gene assays, which fail to detect the differences in activity identified through endogenous gene assays, and fusion protein constructs that alter the transcriptional activation domains and the activities of the Myb proteins.
A-Myb和c-Myb转录因子共享一个高度保守的DNA结合结构域,并且在报告基因检测中激活相同的启动子。然而,这两种蛋白质具有不同的生物学活性,在人类细胞中单独表达它们会导致不同组内源性基因的激活,这表明每种蛋白质都具有独特的转录特异性。在这里,利用内源性基因表达检测来测量特异性变化,对Myb蛋白的结构和功能特征进行了比较。当在不同细胞类型中测试Myb蛋白时,它们在每种细胞环境中激活了独特且几乎不重叠的基因集。缺失和结构域交换实验确定了A-Myb和c-Myb中对于特定基因(如DHRS2、DSIPI和mim-1)调控所必需的小的、离散的正性和负性元件。结果表明,转录激活结构域中的单个功能元件负责以细胞环境特异性的方式激活特定的细胞基因。这些结果对于解释报告基因检测的结果也具有重要意义,报告基因检测未能检测到通过内源性基因检测所确定的活性差异,以及改变转录激活结构域和Myb蛋白活性的融合蛋白构建体。